In the last trading session, 1.91 million shares of the Fulcrum Therapeutics Inc. (NASDAQ:FULC) were traded. Most recently the company’s share price was $30.83, and
During the last session, Fulcrum Therapeutics Inc. (NASDAQ:FULC)’s traded shares were 0.4 million. At the end of the trading day, the stock’s price was $28.07,
In the last trading session, 1.1 million shares of the Fulcrum Therapeutics Inc. (NASDAQ:FULC) were traded. Most recently the company’s share price was $29.70, and
Fulcrum Therapeutics Inc. (NASDAQ:FULC)’s traded shares stood at 1.14 million during the last session. At the close of trading, the stock’s price was $26.41, to
In the last trading session, 1.77 million Fulcrum Therapeutics Inc. (NASDAQ:FULC) shares changed hands as the company’s beta touched 0. With the company’s per share
In last trading session, Fulcrum Therapeutics Inc. (NASDAQ:FULC) saw 1.87 million shares changing hands with its beta currently measuring 0. Company’s recent per share price
Fulcrum Therapeutics Inc. (NASDAQ:FULC) has seen 1.94 million shares traded in the last trading session. The company, currently valued at $696.11M, closed the last trade
During the last session, Fulcrum Therapeutics Inc. (NASDAQ:FULC)’s traded shares were 13.41 million. At the end of the trading day, the stock’s price was $22.45,
The biotechnology industry develops mechanisms for treating health problems and tools for diagnosing them. It usually takes a great deal of research and funding for